Heberprot-P in the treatment of diabetic foot ulcers

Introduction: The diabetic foot is one of the most feared complications of diabetes mellitus; It is the cause of 80 % of non-traumatic amputations worldwide. For decades, different treatments have been used to heal diabetic foot; growth factors have revolutionized this therapy. The participation of...

Full description

Saved in:
Bibliographic Details
Published inRevista cubana de medicina militar Vol. 51; no. 3; p. e02201923
Main Authors Saymara Castillo Deprés, Mothabeng Thabo Geoffrey, Lotty Ledwaba, Thula K. Ngcobo, Natasha Singh MMed, Julio Esmir Baldomero Hernández, Ana Blanca Torres Minkova, Osvaldo Reyes Acosta, Dania Castillo Deprés
Format Journal Article
LanguageSpanish
Published ECIMED 01.06.2022
Subjects
amputación
diabetes mellitus
heberprot-p
pie diabético
trasplante de piel
Online AccessGet full text

Cover

More Information
Summary:Introduction: The diabetic foot is one of the most feared complications of diabetes mellitus; It is the cause of 80 % of non-traumatic amputations worldwide. For decades, different treatments have been used to heal diabetic foot; growth factors have revolutionized this therapy. The participation of a multidisciplinary team with compliance with the action protocols and the use of Heberprot-P decrease the rate of amputations in patients with this condition. Objective: To present the evolution of patients with diabetic foot ulcers, in different clinical stages, treated with Heberprot-P. Development: Three clinical cases are presented; The first is a male patient, 56 years old, diabetic, with open transmetatarsal amputation in which 16 applications of Heberprot-P were performed and a skin graft was placed, the lesion closed in 45 days. The second is a 58-year-old patient, diabetic and hypertensive, with a right foot injury, with previous vascular surgery; 19 applications of Heberprot-P were performed and the lesion healed in 49 days. The third case is a 55-year-old patient, who was admitted due to an extensive injury to his right foot, 22 applications of Heberprot-P were performed, closure of the injury was achieved in 85 days and amputation was avoided. Conclusions: The presented cases evolved favorably with Heberprot-P treatment.
ISSN:1561-3046